Rankings
▼
Calendar
CRMD FY 2025 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$312M
+617.0% YoY
Gross Profit
$276M
88.5% margin
Operating Income
$150M
48.2% margin
Net Income
$163M
52.3% margin
EPS (Diluted)
$2.04
Cash Flow
Operating Cash Flow
$175M
Free Cash Flow
$175M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$826M
Total Liabilities
$421M
Stockholders' Equity
$405M
Cash & Equivalents
$145M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$312M
$43M
+617.0%
Gross Profit
$276M
$40M
+584.6%
Operating Income
$150M
-$22M
+771.6%
Net Income
$163M
-$18M
+1009.4%
← Q4 2024
All Quarters
Q1 2025 →